Skip to Main Content

Advertisement

Skip Nav Destination

Atypical hemolytic uremic syndrome in the era of terminal complement inhibition: an observational cohort study

Blood (2023) 142 (16): 1371–1386.
Currently there are no citedby results. Try again later.
Close Modal

or Create an Account

Close Modal
Close Modal

Advertisement